CYP1B1 and neoplasm: Phase I drug-metabolizing enzymes identified in the human prostate encompass CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A5, and CYP4B1, which are present in both normal and tumorous tissue [9].